rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    VTAK
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Catheter Precision Partners With Two New German Heart Centers
      Nov 16Yahoo FinanceVTAK
      Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population
      Nov 2Yahoo FinanceVTAK
      Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure Device

      FORT MILL, S.C, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced the first published comparative study evaluating its LockeT suture retention device against a traditional internal vascular closure device (VCD) following large bore venous access. The 172-patient peer-reviewed study, titled "Vascular closure with a suture retention device versus suture-mediated closure system after large bore venous acces

      Oct 22Yahoo FinanceABTVTAK
      Flyte Aviation Rebrands and Executes Reverse Stock Split

      Detailed price information for Flyte Aviation Inc (VJET-A) from The Globe and Mail including charting and trades.

      Oct 6The Globe and MailVTAK
      Flyte Aviation Launches Under NYSE American Ticker “VJET”
      Oct 5Yahoo FinanceVTAK
      Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

      LockeT Has Expanded to Six Hospitals in Brazil Since Its August Launch Company Engages Experienced Cardiology Group to Support Expansion Across Argentina, Chile, Colombia and Additional Latin American Markets FORT MILL, S.C., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Catheter Precision Inc. (NYSE American: VTAK), Catheter Precision, Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a U.S.-based medical device company specializing in cardiac electrophysiology, today announced the expan

      Sep 17Yahoo FinanceVTAK
      Catheter Precision's Flyte, Christian Cowan Partner for New York Fashion Week

      Catheter Precision (VTAK) subsidiary Flyte said late Thursday it has entered a strategic partnership

      Sep 10Yahoo FinanceVTAK
      Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
      Sep 2Yahoo FinanceVTAK
      Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

      Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic medical center, Places First Order for LockeT, VTAK’s suture retention device Places its first VIVO 3D Imaging System with a hospital in Germany, one of the largest electrophysiology markets in Europe. FORT MILL, S.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc.’s (NYSE American: VTAK) m

      Aug 27Yahoo FinanceCAHVTAK

      This is the newest page. Registered accounts read further back.